Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Elevance Health (ELV)
NYSE:ELV
Elevance Health (ELV) Stock Price & Analysis
2,012 Followers
ELV Stock Chart & Stats
Day’s Range$533.65 - $539.27
52-Week Range― - ―
Previous Close$533.35
Volume189.55K
Average Volume (3M)N/A
Market Cap
$125.31B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next Earnings
Jul 17, 2024EPS Estimate
$10.03Next Dividend Ex-Date
Jun 10, 2024Dividend Yield1.14%
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$605.83Price Target Upside12.37% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering13
Elevance Health News
Bulls Say, Bears Say
Bulls Say
Earnings PerformanceElevance Health's first quarter results showcased strong earnings, beating expectations with a notable adjusted EPS, underpinned by effective cost management and margin improvements.
Financial OutlookElevance Health's raised adjusted EPS guidance reflects a robust financial outlook, building investor confidence in the company's ability to sustain growth and profitability.
Strategic GrowthThe strategic partnership with Clayton, Dubilier & Rice to delve into primary care and the planned acquisition of Kroger’s specialty pharmacy highlight Elevance Health's commitment to expanding its healthcare delivery services.
Bears Say
Financial PerformanceCarelonRx revenue was below estimates, despite an increase in prescriptions, indicating pricing pressure.
Membership DynamicsTotal membership declined year-over-year, with a particularly sharp decrease in Medicaid membership.
Strategic PartnershipsIf Kroger Specialty Pharmacy shifts from its current distributor, it could result in a roughly 2% headwind to Pharmaceutical revenue for the distributor.
---
Ownership Overview
2.22% Insiders
27.43% Mutual Funds
27.24% Other Institutional Investors
43.11% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Ability to SellRisks related to the company’s ability to sell goods and services
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ELV FAQ
What was Elevance Health’s price range in the past 12 months?
Currently, no data Available
What is Elevance Health’s market cap?
Currently, no data Available
When is Elevance Health’s upcoming earnings report date?
Elevance Health’s upcoming earnings report date is Jul 17, 2024 which is in 68 days.
How were Elevance Health’s earnings last quarter?
Elevance Health released its earnings results on Apr 18, 2024. The company reported $10.64 earnings per share for the quarter, beating the consensus estimate of $10.519 by $0.121.
Is Elevance Health overvalued?
According to Wall Street analysts Elevance Health’s price is currently Undervalued.
Does Elevance Health pay dividends?
Elevance Health pays a Quarterly dividend of $1.63 which represents an annual dividend yield of 1.14%. See more information on Elevance Health dividends here
What is Elevance Health’s EPS estimate?
Elevance Health’s EPS estimate is $10.03.
How many shares outstanding does Elevance Health have?
Currently, no data Available
What happened to Elevance Health’s price movement after its last earnings report?
Elevance Health reported an EPS of $10.64 in its last earnings report, beating expectations of $10.519. Following the earnings report the stock price went up 3.187%.
Which hedge fund is a major shareholder of Elevance Health?
Among the largest hedge funds holding Elevance Health’s share is First Eagle Investment Management LLC. It holds Elevance Health’s shares valued at 839M.
---
Elevance Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$605.83 (12.37% Upside)
$605.83 (12.37% Upside)
Blogger Sentiment
Bullish
ELV Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 455.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $12.5M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.2%
Last 30 Days ▼ 2.0%
Last 30 Days ▼ 2.0%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
16.13%
12-Months-Change
Fundamentals
Return on Equity
16.02%
Trailing 12-Months
Asset Growth
2.62%
Trailing 12-Months
Company Description
Elevance Health
Indiana-based Anthem, Inc. was formed in 2004 after the merger of WellPoint Health Networks Inc. and Anthem, Inc. The company is one of the leading health insurance names, and provides medical benefits through a range of integrated healthcare plans and related services, along with a wide range of specialty products such as life and disability insurance benefits, dental, vision, behavioral health benefit services, as well as long-term care insurance and flexible spending accounts.
---
ELV Company Deck
---
ELV Earnings Call
Q1 2024
0:00 / 0:00
---
ELV Stock 12 Month Forecast
Average Price Target
$605.83
▲(12.37% Upside)
Technical Analysis
Best Analysts Covering ELV
1 Year
1 Year Success Rate
12/14 ratings generated profit
1 Year Average Return
+8.40%
reiterated a buy rating 22 days ago
Copying Kevin Fischbeck's trades and holding each position for 1 Year would result in 85.71% of your transactions generating a profit, with an average return of +8.40% per trade.
---